Clinical Trial Update: Immunotoxin Therapy in Treating Children With Progressive or Recurrent Glioblastoma Multiforme or Anaplastic Astrocytoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating an immunotoxin therapy in children with progressive or recurrent glioblastoma multiforme or anaplastic astrocytoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Glioblastoma Multiforme

Drugs mentioned

• Immunotoxin therapy

Snippet

Sponsor: Xenova Biomedix | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: UNKNOWN